Arginase is overactive in psoriatic skin
- 17 March 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 163 (1), 193-196
- https://doi.org/10.1111/j.1365-2133.2010.09766.x
Abstract
Background Psoriatic keratinocytes are poorly differentiated and hyperproliferative. Low concentrations of nitric oxide (NO) induce keratinocyte proliferation, while high concentrations induce differentiation. The NO‐producing enzyme inducible NO synthase is overexpressed in psoriatic skin, but so is arginase. The overexpressed arginase competes for arginine, the common substrate for both enzymes, and may reduce NO production. Objectives To determine whether arginase activity is elevated in psoriatic skin and whether exogenous NO will improve psoriatic plaques. Methods Tape strips were taken from healthy skin of eight control subjects and nonlesional skin of eight patients with psoriasis and l‐arginine, l‐citrulline and l‐ornithine concentrations measured by high‐performance liquid chromatography. In a second study, four psoriatic patients with a pair of similar symmetrical plaques were treated with an NO donor and vehicle control. Plaques were scored for size, erythema, induration and scaling at the start and after 6 weeks of treatment. Results Ornithine, the end‐product of arginase, was at higher concentrations in nonlesional psoriatic than in healthy skin (mean ± SEM 2·08 ± 0·98 vs. 1·13 ± 0·44 μg mg−1 protein; P = 0·0002). Arginine, its substrate, was at lower concentrations. Topical application of an NO donor improved psoriatic plaques clinically [mean ± SD reduction in severity from baseline score (100%) to 35% ± 16% in active NO donor and to 93% ± 10% in control]. Conclusions Arginase is overactive in psoriatic skin, leading to a relative increase in the consumption of arginine. We therefore hypothesize a relative decrease in NO synthase‐derived NO production. NO donors may be effective topical treatments for psoriasis.Keywords
This publication has 11 references indexed in Scilit:
- A study of serum nitric oxide levels in psoriasisIndian Journal of Dermatology, Venereology and Leprology, 2005
- Arginase 1 Overexpression in PsoriasisThe American Journal of Pathology, 2003
- Biphasic Effect of Exogenous Nitric Oxide on Proliferation and Differentiation in Skin Derived Keratinocytes but Not FibroblastsJournal of Investigative Dermatology, 1998
- Aberrant Timing in Epidermal Expression of Inducible Nitric Oxide Synthase After UV Irradiation in Cutaneous Lupus ErythematosusJournal of Investigative Dermatology, 1998
- Increased expression of inducihie nitric oxide (NO) synthaseBritish Journal of Dermatology, 1997
- Increased expression of inducible nitric oxide synthase in psoriatic skin and cytokine-stimulated cultured keratinocytesBritish Journal of Dermatology, 1996
- Inhibitors of Nitric Oxide Synthase in Human SkinJournal of Investigative Dermatology, 1996
- Expression of inducible nitric oxide synthase in dermal microvasculature in psoriasisThe Lancet, 1994
- Epidermal keratinocyte expression of inducible nitric oxide synthase in skin lesions of psoriasis vulgarisThe Lancet, 1994
- Cutaneous polyamines in psoriasisBritish Journal of Dermatology, 1982